Biochanin A attenuates obesity cardiomyopathy in rats by inhibiting oxidative stress and inflammation through the Nrf-2 pathway

References

• Ahmed, S.M., et al., 2017. Nrf2 signaling pathway: pivotal roles in inflammation. Biochimica et Biophysica Acta. Molecular basis of disease, 1863 (2), 585–597.
   PubMed Web of Science ®Google Scholar
• Alpert, M.A., 2001. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. The American journal of the medical sciences, 321 (4), 225–236.
   PubMed Web of Science ®Google Scholar
• Antony Rathinasamy, J.I.R., et al., 2020. Antiobesity effect of Biochanin-A: effect on trace element metabolism in high fat diet-induced obesity in rats. Cardiovascular & hematological agents in medicinal chemistry, 18 (1), 21–30.
   PubMedGoogle Scholar
• Balaji, M., et al., 2017. Antiobesity potential of Piperonal: promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats. Nutrition & metabolism, 14, 72.
   PubMed Web of Science ®Google Scholar
• Bohula, E.A., et al., 2018. Cardiovascular safety of lorcaserin in overweight or obese patients. New England journal of medicine, 379 (12), 1107–1117.
   PubMed Web of Science ®Google Scholar
• Bonting, S. L., 1970. Sodium potassium activated adenosine triphosphatase and cation transport. In: Bitler E.E. ed. Membrane and ion transport. Vol-1. London: Interscience Wiley, 257–263.
   Google Scholar
• Brahma Naidu, P., et al., 2016. Ameliorative potential of gingerol: promising modulation of inflammatory factors and lipid marker enzymes expressions in HFD induced obesity in rats. Molecular and cellular endocrinology, 419, 139–147.
   PubMed Web of Science ®Google Scholar
• Brahmanaidu, P., et al., 2017. Reversal of endothelial dysfunction in aorta of streptozotocin-nicotinamide-induced type-2 diabetic rats by S-Allylcysteine. Molecular and cellular biochemistry, 432 (1–2), 25–32.
   PubMed Web of Science ®Google Scholar
• Bray, G.A., et al., 2018. The science of obesity management: an endocrine society scientific statement. Endocrine reviews, 39 (2), 79–132.
   PubMed Web of Science ®Google Scholar
• Cavalera, M., Wang, J., and Frangogiannis, N.G., 2014. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Translational research: the journal of laboratory and clinical medicine, 164 (4), 323–335.
   PubMed Web of Science ®Google Scholar
• Chang, X.X., et al., 2012. The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. Lipids in health and disease, 11, 86.
   PubMed Web of Science ®Google Scholar
• Chen, X.L., et al., 2006. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. American journal of physiology: heart and circulatory physiology, 290, 1862–1870.
   PubMed Web of Science ®Google Scholar
• Csige, I., et al., 2018. The impact of obesity on the cardiovascular system. Journal of Diabetes Research, 2018, 3407306.
   PubMed Web of Science ®Google Scholar
• de Freitas Junior, L.M., and de Almeida, E.B., Jr., 2017. Medicinal plants for the treatment of obesity: ethnopharmacological approach and chemical and biological studies. American Journal of Translational Research, 9 (5), 2050–2064.
   PubMed Web of Science ®Google Scholar
• Esser, N., et al., 2014. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice, 105 (2), 141–150.
   PubMed Web of Science ®Google Scholar
• Fernandez-Sanchez, A., et al., 2011. Inflammation, oxidative stress, and obesity. International Journal of Molecular Sciences, 12, 3117–3132.
   PubMed Web of Science ®Google Scholar
• Govindasami, S., et al., 2020. Therapeutic potential of biochanin-A against isoproterenol -induced myocardial infarction in rats. Cardiovascular & Hematological Agents in Medicinal Chemistry, 18 (1), 31–36.,
   PubMedGoogle Scholar
• Hariri, N., and Thibault, L., 2010. High-fat diet-induced obesity in animal models. Nutrition Research Reviews, 23 (2), 270–299.
   PubMed Web of Science ®Google Scholar
• Kalaivani, A., et al., 2019. Reversal of high fat diet-induced obesity through modulating lipid metabolic enzymes and inflammatory markers expressions in rats. Archives of Physiology and Biochemistry, 125 (3), 228–234.
   PubMed Web of Science ®Google Scholar
• Kalaivani, A., et al., 2020., Attenuation of obesity-associated oxidative stress by cucurbita maxima seed oil in high fat diet-induced obese rats. In: Tappia P., Ramjiawan B., Dhalla N. eds. Pathophysiology of obesity-induced health complications. Advances in biochemistry in health and disease 19. Cham: Springer.
   Google Scholar
• Kansanen, E., et al., 2013. The keap1-nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biology, 1, 45–49.
   PubMed Web of Science ®Google Scholar
• Kaplan, J.H., 2002. Biochemistry of Na,K-ATPase. Annual Review of Biochemistry, 71, 511–535.
   PubMed Web of Science ®Google Scholar
• Kim, E.N., et al., 2019. High serum CRP influences myocardial miRNA profiles in ischemia-reperfusion injury of rat heart. PLoS One, 14 (5), e0216610.
   PubMed Web of Science ®Google Scholar
• Kim, M.S., et al., 2013. Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone. PLoS One, 8 (12), e82847.
   PubMed Web of Science ®Google Scholar
• Kobayashi, E.H., et al., 2016. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nature Communications, 7, 11624.
   PubMed Web of Science ®Google Scholar
• Leger, T., et al., 2018. Dietary canolol protects the heart against the deleterious effects induced by the association of rapeseed oil, vitamin E and coenzyme Q10 in the context of a high-fat diet. Nutrition & Metabolism, 15, 15.
   PubMed Web of Science ®Google Scholar
• Li, C.H., et al., 2017. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. European Journal of Pharmacology, 811, 74–86.
   PubMed Web of Science ®Google Scholar
• Lim, H.Y., and Bodmer, R., 2011. Phospholipid homeostasis and lipotoxic cardiomyopathy: a matter of balance. Fly, 5 (3), 234–236.
   PubMed Web of Science ®Google Scholar
• Liu, C., et al., 2012. Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis. The journal of biological chemistry, 287 (20), 16390–16398.
   PubMed Web of Science ®Google Scholar
• Marín-Royo, G., et al., 2018. Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity. Disease models & mechanisms, 11, 032086. https://doi.org/10.1242/dmm.032086.
   Web of Science ®Google Scholar
• Marín-Royo, G., et al., 2019. The impact of cardiac lipotoxicity on cardiac function and mirnas signature in obese and non-obese rats with myocardial infarction. Scientific reports, 9 (1), 444.
   PubMedGoogle Scholar
• Martinez-Martinez, E., et al., 2014. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. Journal of hypertension, 32, 1104–1114.
   PubMed Web of Science ®Google Scholar
• Márton, M., et al., 2018. NRF2-regulated cell cycle arrest at early stage of oxidative stress response mechanism. PLoS one, 13 (11), e0207949.
   PubMed Web of Science ®Google Scholar
• McCully, K.S., 2005. Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clinical chemistry and laboratory medicine, 43 (10), 980–986.
   PubMed Web of Science ®Google Scholar
• McNamara, D.J., 2000. Dietary cholesterol and atherosclerosis. Biochimica et Biophysica Acta (BBA) – Molecular and cell biology of lipids, 1529 (1–3), 310–320.
   PubMed Web of Science ®Google Scholar
• Mohamed, A.R., El-Hadidy, W.F., and Mannaa, H.F., 2014. Assessment of the prophylactic role of aspirin and/or clopidogrel on experimentally induced acute myocardial infarction in hypercholesterolemic rats. Drugs in R&D, 14 (4), 233–239.
   PubMedGoogle Scholar
• Naidu, P.B., et al., 2016. Effects of S-allylcysteine on biomarkers of the polyol pathway in rats with type 2 diabetes. Canadian journal of diabetes, 40 (5), 442–448.
   PubMed Web of Science ®Google Scholar
• Ng, M., et al., 2014. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 384 (9945), 766–781.
   PubMed Web of Science ®Google Scholar
• Novelli, E.L., et al., 2007. Anthropometrical parameters and markers of obesity in rats. Laboratory animals, 41 (1), 111–119.
   PubMed Web of Science ®Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95 (2), 351–358.
   PubMed Web of Science ®Google Scholar
• Oliver, M.F., 2006. Sudden cardiac death: the lost fatty acid hypothesis. QJM: monthly journal of the association of physicians, 99 (10), 701–709.
   PubMed Web of Science ®Google Scholar
• Olusi, S.O., 2002. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. International journal of obesity, 26 (9), 1159–1164.
   PubMed Web of Science ®Google Scholar
• Rameshreddy, P., et al., 2018. Obesity-alleviating potential of asiatic acid and its effects on ACC1, UCP2, and CPT1 mRNA expression in high fat diet-induced obese Sprague-Dawley rats. Molecular and cellular biochemistry, 442 (1–2), 143–154.
   PubMed Web of Science ®Google Scholar
• Redondo Useros, N., et al., 2019. 2-OHOA supplementation reduced adiposity and improved cardiometabolic risk to a greater extent than n-3 PUFA in obese mice. Obesity research & clinical practice, 13 (6), 579–585.
   PubMed Web of Science ®Google Scholar
• Rodrigues, A., et al., 2012. Food intake, body mass index and body fat mass in elderly. Asian journal of clinical nutrition, 4 (3), 107–115.
   Google Scholar
• Saravanan, G., et al., 2013. Cardioprotective activity of Amaranthus viridis Linn: effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. International journal of cardiology, 165 (3), 494–498.
   PubMed Web of Science ®Google Scholar
• Sathibabu Uddandrao, V.V., et al., 2018. Beneficial role of some natural products to attenuate the diabetic cardiomyopathy through Nrf2 pathway in cell culture and animal models. Cardiovascular toxicology, 18 (3), 199–205.
   PubMed Web of Science ®Google Scholar
• Sathibabu Uddandrao, V.V., et al., 2019. Restorative potentiality of S-allylcysteine against diabetic nephropathy through attenuation of oxidative stress and inflammation in streptozotocin-nicotinamide-induced diabetic rats. European journal of nutrition, 58 (6), 2425–2437.
   PubMed Web of Science ®Google Scholar
• Sathibabu Uddandrao, V.V., Brahmanaidu, P., and Saravanan, G., 2018. Therapeutical perspectives of S-allylcysteine: effect on diabetes and other disorders in animal models. Cardiovascular & hematological agents in medicinal chemistry, 15 (2), 71–77.
   Google Scholar
• Seo, W.K., et al., 2017. Free fatty ok, acid I. associated with thrombogenicity in cardioembolic stroke. Cerebrovascular diseases, 44 (3–4), 160–168.,
   PubMed Web of Science ®Google Scholar
• Singh, R., and Krishan, P., 2010. Modulation of impact of high fat diet in pathological and physiological left ventricular cardiac hypertrophy by fluvastatin. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 64 (3), 147–153.
   PubMed Web of Science ®Google Scholar
• Sun, X., et al., 2012. High free fatty acids level related with cardiac dysfunction in obese rats. Diabetes research and clinical practice, 95 (2), 251–259.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., and Yamamoto, M., 2015. Molecular basis of the keap1-nrf2 system. Free radical biology & medicine, 88 (Pt B), 93–100.
   PubMed Web of Science ®Google Scholar
• Taube, A., et al., 2012. Inflammation and metabolic dysfunction: links to cardiovascular diseases. American journal of physiology: heart and circulatory physiology, 302, 2148–2165.
   PubMed Web of Science ®Google Scholar
• Uddandrao, V.V.S., et al., 2020. Antiobesity efficacy of asiatic acid: down-regulation of adipogenic and inflammatory processes in high fat diet induced obese rats. Archives of physiology and biochemistry, 126 (5), 453–462.
   PubMed Web of Science ®Google Scholar
• Wende, A.R., Symons, J.D., and Abel, E.D., 2012. Mechanisms of lipotoxicity in the cardiovascular system. Current hypertension reports, 14 (6), 517–531.
   PubMed Web of Science ®Google Scholar
• Wilson, C., 2013. Obesity: finding weight loss strategies that work in primary care. Nature reviews. endocrinology, 9 (3), 126–130.
   PubMedGoogle Scholar
• Wong, C., and Marwick, T.H., 2007. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nature clinical practice. Cardiovascular medicine, 4 (8), 436–443.
   PubMedGoogle Scholar
• Woods, S.C., and Seeley, R.J., 2002. Understanding the physiology of obesity: review of recent developments in obesity research. International journal of obesity, 26 (S4), S8–S10.
   Google Scholar
• Yazici, D., and Sezer, H., 2017. Insulin resistance, obesity and lipotoxicity. Advances in experimental medicine and biology, 960, 277–304.
   PubMed Web of Science ®Google Scholar
• Zeng, C., et al., 2015. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. Journal of molecular and cellular cardiology, 79, 1–12.
   PubMed Web of Science ®Google Scholar
• Zhou, B., et al., 2013. Fibrinogen facilitates atherosclerotic formation in Sprague-Dawley rats: a rodent model of atherosclerosis. Experimental and therapeutic medicine, 5 (3), 730–734.
   PubMed Web of Science ®Google Scholar